School of Medicine
Showing 1-10 of 11 Results
-
Laura Michele Hack
Assistant Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
BioDr. Laura Hack is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences and Director of Novel & Precision Neurotherapeutics at the Stanford Center for Precision Mental Health and Wellness. Dr. Hack's translational research program focuses on identifying bioclinical subtypes of depression and comorbid stress-related disorders and testing mechanistically-guided treatments for these subtypes. Dr. Hack studies treatments spanning repurposed medications, such as pramipexole and guanfacine, neuromodulation techniques, ketamine, MDMA, and psilocybin.
Dr. Hack directs the Stanford Translational Precision Mental Health Clinic (STPMHC), a cutting-edge consultation clinic for patients with a primary diagnosis of depression and comorbid anxiety disorders. Providers in the clinic integrate objective measures with a patient's history and presentation to inform treatment considerations and provide insights into the biological basis of a patient's condition. These measures, which may also help reduce self-blame and foster motivation to pursue recommended treatments, include the investigational use of clinical circuit scores derived from functional magnetic resonance imaging, symptom questionnaires, objective neurocognitive assessments, pharmacogenomic testing, and laboratory work. Patients and their referring doctors receive a detailed report with an explanation of the findings and the implications for treatment.
Additionally, as Deputy Director of the Precision Neuromodulation Clinic (PNC) within the VA Palo Alto Health Care System, she specializes in delivering novel treatments, including repetitive transcranial magnetic stimulation (rTMS) and ketamine, to patients suffering from treatment-resistant depression and comorbid stress-related disorders. -
Haijing Wu Hallenbeck
Instructor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psych/Public Mental Health & Population SciencesBioHaijing Hallenbeck, PhD, is a research investigator at the National Center for PTSD Dissemination & Training Division at VA Palo Alto Health Care System. She is also an Instructor (Affiliated) in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She received her PhD in Clinical Psychology from Washington University in St. Louis and completed her predoctoral clinical internship and postdoctoral research fellowship at VA Palo Alto Health Care System. Funded by the VA VISN 21 Early Career Award Program, Dr. Hallenbeck's research focuses on PTSD and depression and their impact on psychosocial functioning. She studies how to leverage digital health technology (e.g., mobile apps) and analytic tools (e.g., machine learning) to provide timely and personalized assessments and interventions for these conditions.
Email: haijing.hallenbeck@stanford.edu -
Kate Hardy
Clinical Professor, Psychiatry and Behavioral Sciences
BioKate Hardy is a California Licensed Psychologist who has specialized in working with individuals with psychosis for over 15 years in both research and clinical settings. Dr. Hardy received her doctorate in clinical psychology from the University of Liverpool, United Kingdom. She has worked in specialist early psychosis services in both the UK and the US, including UCSF’s Prodrome Assessment Research and Treatment (PART) program, where she completed her post-doctoral fellowship, and as Clinical Director for the Prevention and Recovery from Early Psychosis (PREP) program. Dr. Hardy has significant experience in providing CBTp to individuals with early psychosis, and those at risk of developing psychosis, in both individual and group settings and integration of this clinical intervention to broader systems and staff teams. She has led multiple trainings and workshops in CBTp to a wide variety of audiences including community clinicians, psychiatrists, and families, and provides ongoing supervision and consultation in this approach. Dr. Hardy is also involved in the implementation of national strategies to increase dissemination of early psychosis models with the aim of bringing these cutting edge treatments to a broader population.
-
Alesha Heath
Basic Life Research Scientist, Psych/Public Mental Health & Population Sciences
BioDr. Alesha Heath is a Postdoctoral Scholar at Psychiatry and Behavioral Sciences at Stanford School of Medicine and the MIRECC the VA Palo Alto. She earned her PhD from the University of Western Australia and Sorbonne University.
Dr. Heath's research has been primarily focused on the mechanisms and applications of brain stimulation therapies, in particular repetitive transcranial magnetic stimulation. Her research involves both basic and clinical components with the aim of improving the efficacy of these therapies for the treatment of disorders such as depression and Alzheimer's disease. -
Keith Humphreys
Esther Ting Memorial Professor
Current Research and Scholarly InterestsDr. Humphreys researches individual and societal level interventions for addictive and psychiatric disorders. He focuses particularly on evaluating the outcomes of professionally-administered treatments and peer-operated self-help groups (e.g., Alcoholics Anonymous), and, analyzing the impact of public policies touching addiction, mental health, public health, and public safety.
